PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Nov-2023 Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-Line Treatment for Upper GI Cancers Businesswire
07-Nov-2023 Redwire Corporation Reports Third Quarter 2023 Financial Results Businesswire
07-Nov-2023 Gilead and Arcus Announce New Data Showing Encouraging Clinical Activity of Anti-TIGIT Domvanalimab-Containing Regimen as First-line Treatment for Upper GI Cancers Businesswire
07-Nov-2023 MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock Businesswire
07-Nov-2023 El Committee to Restore Nymox Shareholder Value proporciona información actualizada a los accionistas de Nymox sobre la Asamblea Especial Businesswire
07-Nov-2023 Das Committee to Restore Nymox Shareholder Value informiert die Nymox-Aktionäre über die außerordentlichen Versammlung Businesswire
07-Nov-2023 Fabrinet Announces First Quarter Fiscal Year 2024 Financial Results Businesswire
07-Nov-2023 Aura Biosciences Announces Proposed Public Offering of Common Stock Businesswire
07-Nov-2023 Werner Appoints Michelle D. Greene to Board of Directors Businesswire
07-Nov-2023 Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Progress Businesswire
06-Nov-2023 Aura Biosciences Receives FDA Agreement Under Special Protocol Assessment (SPA) for CoMpass Phase 3 Clinical Trial of Belzupacap Sarotalocan (Bel-sar) in Early-stage Choroidal Melanoma Businesswire
06-Nov-2023 Brainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc. Businesswire
06-Nov-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Barclays PLC (BCS, BCLYF) on Behalf of Investors Businesswire
06-Nov-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Brainstorm Cell Therapeutics Inc. (BCLI) on Behalf of Investors Businesswire
06-Nov-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AdaptHealth Corp. (AHCO) on Behalf of Investors Businesswire
06-Nov-2023 Le Committee to Restore Nymox Shareholder Value (CRNSV) communique aux actionnaires de Nymox une mise à jour concernant l’assemblée extraordinaire Businesswire
06-Nov-2023 MedinCell at the 2023 Jefferies Global Healthcare Conference - London, 14-16 November Businesswire
06-Nov-2023 Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2023 Businesswire
06-Nov-2023 Global Solid-State Battery Market Poised for Remarkable Growth with a Projected CAGR of 33.54% from 2023 to 2032 - ResearchAndMarkets.com Businesswire
06-Nov-2023 JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer’s Disease Businesswire